Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2026 ASCO GI
SUO 2025
SABCS 2025
ASH 2025
JADPRO Live 2025
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
2017 ASCO Annual Meeting,2017 ASCO Annual Meeting
«
1
»
Advertisement
Advertisement
Jan
21
Today In Oncology
Breast Cancer Recurrence Risk Determined by Deep Learning Model Trained on Histopathologic Slides
Regulatory Agencies Establish Principles of Good AI Use in Drug Development
Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC
IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer
KEYNOTE-905: Perioperative Immunotherapy Regimen Active in Cisplatin-Ineligible MIBC
View More
Advertisement
